AVEO Pharmaceuticals, Inc. Free Cash Flow 2010-2022 | AVEO
AVEO Pharmaceuticals, Inc. free cash flow from 2010 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| AVEO Pharmaceuticals, Inc. Annual Free Cash Flow |
| 2021 |
-57.26 |
| 2020 |
-38.35 |
| 2019 |
-2.92 |
| 2018 |
-25.03 |
| 2017 |
-19.16 |
| 2016 |
-31.07 |
| 2015 |
-17.01 |
| 2014 |
-67.00 |
| 2013 |
-88.07 |
| 2012 |
-115.68 |
| 2011 |
23.82 |
| 2010 |
-53.51 |
| 2009 |
-11.71 |
| AVEO Pharmaceuticals, Inc. Quarterly Free Cash Flow |
| 2022-09-30 |
-10.48 |
| 2022-06-30 |
-10.67 |
| 2022-03-31 |
-8.22 |
| 2021-12-31 |
-57.26 |
| 2021-09-30 |
-45.07 |
| 2021-06-30 |
-37.00 |
| 2021-03-31 |
-18.33 |
| 2020-12-31 |
-38.35 |
| 2020-09-30 |
-25.32 |
| 2020-06-30 |
-19.32 |
| 2020-03-31 |
-11.79 |
| 2019-12-31 |
-2.92 |
| 2019-09-30 |
4.45 |
| 2019-06-30 |
-14.47 |
| 2019-03-31 |
-8.46 |
| 2018-12-31 |
-25.03 |
| 2018-09-30 |
-18.41 |
| 2018-06-30 |
-15.60 |
| 2018-03-31 |
-6.52 |
| 2017-12-31 |
-19.16 |
| 2017-09-30 |
-15.42 |
| 2017-06-30 |
-12.45 |
| 2017-03-31 |
-5.41 |
| 2016-12-31 |
-31.07 |
| 2016-09-30 |
-23.62 |
| 2016-06-30 |
-14.91 |
| 2016-03-31 |
-10.32 |
| 2015-12-31 |
-17.01 |
| 2015-09-30 |
-17.01 |
| 2015-06-30 |
-26.03 |
| 2015-03-31 |
-14.89 |
| 2014-12-31 |
-67.00 |
| 2014-09-30 |
-55.92 |
| 2014-06-30 |
-47.05 |
| 2014-03-31 |
-27.57 |
| 2013-12-31 |
-88.07 |
| 2013-09-30 |
-78.76 |
| 2013-06-30 |
-55.45 |
| 2013-03-31 |
-22.37 |
| 2012-12-31 |
-115.68 |
| 2012-09-30 |
-86.54 |
| 2012-06-30 |
-60.64 |
| 2012-03-31 |
-31.73 |
| 2011-12-31 |
23.82 |
| 2011-09-30 |
44.53 |
| 2011-06-30 |
44.26 |
| 2011-03-31 |
92.54 |
| 2010-12-31 |
-53.51 |
| 2010-09-30 |
-49.47 |
| 2010-06-30 |
-29.34 |
| 2010-03-31 |
-25.93 |
| 2009-12-31 |
-11.71 |
| 2009-09-30 |
-1.55 |
| 2009-06-30 |
0.70 |
| 2009-03-31 |
4.86 |
